RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
-
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome.
Authors: Manfredi Tesauro, Francesca Schinzari, Valentina Rovella, Domenico Melina, Nadia Mores, Angela Barini, Marco Mettimano, Davide Lauro, Micaela Iantorno, Michael J Quon,…
Diabetes care 2008 Jul -
siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
Authors: Reginald L Austin, Anna Rune, Karim Bouzakri, Juleen R Zierath, Anna Krook
Diabetes 2008 Aug
Thought leaders and organizations working on research involving TNF α.
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- GlaxoSmithKline
- National Taiwan University Hospital
- UPECLIN HC FM Botucatu Unesp
- Isis Pharmaceuticals
- Karolinska Institutet
- University of Western Ontario
- Kennedy Institute of Rheumatology Division
- Università di Tor Vergata
- Universidad de Buenos Aires
-
Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease
conditions: Hepatitis C Virus Infection ; Chronic Liver Disease
interventions: TNF-alpha and IL-10
-
Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy
conditions: Arthritis, Rheumatoid ; Rheumatoid Arthritis
interventions: Ofatumumab ; Placebo
